
Insugen Refil 30/70 Inj 100 IU 3 ml Cartridges
Salt Composition: Insulin Isophane (70%) + Human insulin (30%)
Expiry Date: 01/2028
Inclusive of all taxes
5 Cartridge
About The Product
Premix for both meal-time and baseline sugar control.
Description
Insugen Refil 30/70 Inj 100 IU 3 ml Cartridges is an antidiabetic agents prescription from a healthcare professional. This insulin formulation helps control blood glucose levels in patients with diabetes.
It contains two active ingredients: Insulin Isophane (70%) + Human insulin (30%). It is used in the treatment of diabetes mellitus (type 1 and type 2) to improve blood sugar in both children and adults.
Doctor prescription is still required to ensure safe and effective treatment option.
Uses
- Improve blood sugar level
Side Effects
Every medication shows several types of side effects, Insugen Refil 30/70 Inj 100 IU 3 ml Cartridges also causes certain symptoms which are harmful to the body. Common ones include:
- Low blood sugar (Hypoglycaemia)
- Lightheadedness
- Dizziness
- Anxiety
- Nervousness
- Tiredness
- Feeling hungry
- Visual disturbances
- Headache
- Shaking
- Sweating
- Pale skin
- Skin rashes
- Pain, redness, swelling at injection site.
How To Use
- Insugen Refil Cartridges should be taken with or without food at the fixed time everyday to enhance the effectiveness of the medication.
- Do not self administer without proper medical guidance as it may increase the risk of side effects.
- Always follow the recommended dosage as directed by the doctor.
How It Works
Insugen Refil cartridge contains two active drug which help reduce the blood sugar level and improve the effectiveness of the medication.
Doctor prescription is mandatory during the treatment to ensure safe and effective treatment option.
Safety Advice
FAQs
Insugen Refil 30/70 Inj is a combination of two medications.
It is used in the treatment of diabetes mellitus (type 1 and type 2) to improve blood sugar control both in adults and children.
References
- Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A. (2002). Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients. Diabetic Medicine, 19(5), 393-399.
- Mattoo, V., Milicevic, Z., Malone, J. K., Schwarzenhofer, M., Ekangaki, A., Levitt, L. K., ... & Ramadan Study Group. (2003). A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes research and clinical practice, 59(2), 137-143.
- Pørksen, N., Nyholm, B., Veldhuis, J. D., Butler, P. C., & Schmitz, O. (1997). In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. American Journal of Physiology-Endocrinology and Metabolism, 273(5), E908-E914.
- Pickup, J. (1989). Human insulin. BMJ: British Medical Journal, 299(6706), 991.
- Barnett, A. H., & Owens, D. R. (1997). Insulin analogues. The Lancet, 349(9044), 47-51.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
